103 Because megacolon is believed to be the end result of chronic dilatation,140, 170 it is the author's firm belief that initial dietary efforts should be directed to reducing fecal bulk and thus introducing a low-residue diet
Build EMAR hard stops and running totals
CMS.gov, Medicare GLP-1 Bridge program announcement Wegovy is FDA-approved for chronic weight management (BMI 30+, or 27+ with a weight-related comorbidity) and for cardiovascular risk reduction in adults with established CVD it is a weight-loss and CV drug, not a diabetes drug
If youre past the 56-day in-use window and the pen looks fine, the safe answer is still to discard
Sirtuins regulate gene expression, DNA repair, mitochondrial biogenesis, inflammation, and circadian rhythm but are directly dependent on adequate NAD+ availability to function
Studies show that weight regain is common within 12 months of discontinuing GLP-1 therapy, with many individuals regaining two-thirds of what they lost (PubMed)